Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

This document is an administrative response to comments regarding LCD DL38966 and records the comment and notice periods and a title revision to 'MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer.' The provided text contains no clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits to extract.